Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,378,278
  • Shares Outstanding, K 46,810
  • Annual Sales, $ 1,361 M
  • Annual Income, $ 167,680 K
  • EBIT $ 277 M
  • EBITDA $ 407 M
  • 60-Month Beta 0.29
  • Price/Sales 2.55
  • Price/Cash Flow 10.27
  • Price/Book 4.20

Options Overview Details

View History
  • Implied Volatility 48.87% (+1.43%)
  • Historical Volatility 31.18%
  • IV Percentile 73%
  • IV Rank 47.95%
  • IV High 72.27% on 10/21/25
  • IV Low 27.31% on 12/08/25
  • Expected Move (DTE 32) 7.34 (10.16%)
  • Put/Call Vol Ratio 1.00
  • Today's Volume 36
  • Volume Avg (30-Day) 119
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 5,039
  • Open Int (30-Day) 5,391
  • Expected Range 64.83 to 79.51

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.27
  • Number of Estimates 6
  • High Estimate 1.28
  • Low Estimate 1.26
  • Prior Year 1.19
  • Growth Rate Est. (year over year) +6.72%

Price Performance

See More
Period Period Low Period High Performance
1-Month
71.61 +0.78%
on 01/16/26
86.11 -16.19%
on 01/08/26
-8.94 (-11.02%)
since 12/16/25
3-Month
48.98 +47.35%
on 10/29/25
87.32 -17.35%
on 12/10/25
+22.40 (+45.01%)
since 10/16/25
52-Week
47.31 +52.53%
on 09/26/25
87.32 -17.35%
on 12/10/25
-1.36 (-1.85%)
since 01/16/25

Most Recent Stories

More News
1 Cash-Producing Stock Worth Your Attention and 2 Facing Challenges

1 Cash-Producing Stock Worth Your Attention and 2 Facing Challenges

BELFA : 182.73 (+2.10%)
HAE : 72.17 (-2.47%)
VC : 93.69 (-3.95%)
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics

$11 million in proceeds expected to be received during 2026, with remainder of expected proceeds to be received in future revenue earnouts Vivasure Medical Limited (“Vivasure”) has been a strategic...

OBIO : 4.22 (+1.20%)
HAE : 72.17 (-2.47%)
Haemonetics Acquires Vivasure Medical Limited

BOSTON , Jan. 9, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today...

HAE : 72.17 (-2.47%)
1 Small-Cap Stock Worth Your Attention and 2 We Avoid

1 Small-Cap Stock Worth Your Attention and 2 We Avoid

CBZ : 50.79 (-1.40%)
FCFS : 171.10 (+1.24%)
HAE : 72.17 (-2.47%)
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026

BOSTON , Jan. 7, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2026 financial results at 6:00 am ET on Thursday,...

HAE : 72.17 (-2.47%)
Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference

BOSTON , Jan. 2, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco...

HAE : 72.17 (-2.47%)
3 Low-Volatility Stocks We Think Twice About

3 Low-Volatility Stocks We Think Twice About

TOWN : 35.07 (-0.68%)
CDRE : 43.61 (+0.07%)
HAE : 72.17 (-2.47%)
Why Haemonetics (HAE) Shares Are Trading Lower Today

Why Haemonetics (HAE) Shares Are Trading Lower Today

HAE : 72.17 (-2.47%)
Why Haemonetics (HAE) Stock Is Down Today

Why Haemonetics (HAE) Stock Is Down Today

HAE : 72.17 (-2.47%)
3 Unpopular Stocks We Steer Clear Of

3 Unpopular Stocks We Steer Clear Of

HAE : 72.17 (-2.47%)
DENN : 6.25 (-0.16%)
HG : 26.16 (-0.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood...

See More

Key Turning Points

3rd Resistance Point 76.62
2nd Resistance Point 75.50
1st Resistance Point 73.84
Last Price 72.17
1st Support Level 71.06
2nd Support Level 69.94
3rd Support Level 68.28

See More

52-Week High 87.32
Last Price 72.17
Fibonacci 61.8% 72.04
Fibonacci 50% 67.32
Fibonacci 38.2% 62.60
52-Week Low 47.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar